Anti-arrhythmic effects of selective inhibition of myocardial phosphodiesterase II

This publication has 8 references indexed in Scilit:

• Selective inhibition of the cGMP-stimulated cyclic nucleotide phosphodiesterase from pig and human myocardium
  Journal of Molecular and Cellular Cardiology, 1992
• Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: Implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors
  Journal of the American College of Cardiology, 1992
• Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
  New England Journal of Medicine, 1991
• The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
  Circulation, 1991
• cGMP inhibits the activity of single calcium channels in embryonic chick heart cells.
  Circulation Research, 1991
• CYCLIC A.M.P. AND ARRHYTHMIAS REVISITED
  The Lancet, 1978
• The Role of Cyclic Adenosine Monophosphate in Adrenergic Effects on Ventricular Vulnerability to Fibrillation in the Isolated Perfused Rat Heart
  Journal of Clinical Investigation, 1978
• CYCLIC ADENOSINE MONOPHOSPHATE, VENTRICULAR FIBRILLATION, AND ANTIARRHYTHMIC DRUGS
  The Lancet, 1976